NEXGEL, Inc. (NXGLW) shareholders
NXGLWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGL
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 6/3072% below fair value
$0.01+0.00 (0.00%)
Close on Oct 30, 2026Market cap $34.21MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
1M
Shares held, 13F filers
Institutional holders
6
1 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 12 sales
Net sold $46.81K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Asymmetry Point LP Joint filing with Asymmetry Point Capital LLC (8.80%), Mr. Aviv Argaman (8.80%) | 745,000 | 8.80% | 13G (passive) amendment | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of NXGLW | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 550,000 | – | $21.23K | – | 0.00% |
| Warberg Asset Management LLC | 145,591 | – | $4.75K | −500 | 0.00% |
| Empery Asset Management, LP | 90,000 | – | $3.47K | – | 0.00% |
| Clear Street Group Inc. | 50,814 | – | $1.96K | +200 | 0.00% |
| Two Sigma Securities, LLC | 21,875 | – | $584 | New | 0.00% |
| UBS Group AG | 15,081 | – | $407 | −1,000 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 6 | 1M | 1 / 1 | 2 / 0 | 0M | 0M |
| Q1 2026 | 5 | 1M | 0 / 1 | 1 / 1 | 0M | 0M |
| Q4 2025 | 6 | 1M | 2 / 1 | 1 / 0 | 0M | 0M |
| Q3 2025 | 4 | 1M | 1 / 0 | 2 / 0 | 0M | 0M |
| Q2 2025 | 4 | 1M | 0 / 0 | 3 / 1 | 0M | 0M |
| Q1 2025 | 5 | 1M | 2 / 1 | 0 / 0 | 0M | 0M |
| Q4 2024 | 3 | 1M | 1 / 0 | 1 / 1 | 0M | 0M |
| Q3 2024 | 3 | 1M | 0 / 0 | 1 / 1 | 0M | 0M |
| Q2 2024 | 4 | 1M | 1 / 0 | 0 / 0 | 0M | 0M |
| Q1 2024 | 3 | 1M | 0 / 0 | 1 / 0 | 0M | 0M |
| Q4 2023 | 3 | 1M | 0 / 0 | 1 / 1 | 0M | 0M |
| Q3 2023 | 4 | 1M | 0 / 0 | 1 / 1 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Adam R. Levy | Chief Executive Officer, Director | 322,692 | Jul 29, 2026 |
| Ian Howard Blackman | Chief Financial Officer | – | May 7, 2026 |
| Joseph F. McGuire | Chief Financial Officer | 4,082 | Jan 6, 2025 |
| Adam E. Drapczuk III | Chief Financial Officer | 99,994 | Nov 22, 2024 |
| Scott Robert Henry | Director | 113,356 | May 18, 2026 |
| Brian Joseph Kieser | Director | – | May 18, 2026 |
| Kevin McClain Harris | Director | – | May 18, 2026 |
| Steven Ciardiello | Director | 21,739 | Aug 5, 2025 |
| John Nachum Stein | Director | 471,456 | Jun 27, 2025 |
| Jerome B. Zeldis | Director | 106,664 | Jun 27, 2025 |
| steven mark glassman | Director | 156,655 | Jun 27, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Adam R. Levy Chief Executive Officer, Director | Jun 23, 2026 | Sale | −5,000 | $0.59 | $2.95K | 322,692 |
| Adam R. Levy Chief Executive Officer, Director | Jun 18, 2026 | Sale | −6,000 | $0.59 | $3.54K | 327,692 |
| Adam R. Levy Chief Executive Officer, Director | Jun 11, 2026 | Sale | −3,000 | $0.61 | $1.83K | 333,692 |
| Adam R. Levy Chief Executive Officer, Director | Jun 8, 2026 | Sale | −3,000 | $0.55 | $1.65K | 336,692 |
| Adam R. Levy Chief Executive Officer, Director | Jun 4, 2026 | Sale | −3,000 | $0.59 | $1.77K | 339,692 |
| Adam R. Levy Chief Executive Officer, Director | Jun 1, 2026 | Sale | −2,000 | $0.59 | $1.18K | 342,692 |
| Adam R. Levy Chief Executive Officer, Director | May 29, 2026 | Sale | −3,000 | $0.60 | $1.80K | 344,692 |
| Adam R. Levy Chief Executive Officer, Director | May 28, 2026 | Sale | −7,000 | $0.61 | $4.27K | 347,692 |
| Adam R. Levy Chief Executive Officer, Director | May 27, 2026 | Sale | −3,000 | $0.60 | $1.80K | 354,692 |
| Adam R. Levy Chief Executive Officer, Director | Dec 24, 2025 | Sale | −4,000 | $1.57 | $6.28K | 357,692 |
| Adam R. Levy Chief Executive Officer, Director | Dec 22, 2025 | Sale | −6,000 | $1.61 | $9.66K | 361,692 |
| Adam R. Levy Chief Executive Officer, Director | Nov 6, 2025 | Sale(10b5-1 plan) | −4,000 | $2.52 | $10.08K | 367,692 |
| Adam R. Levy Chief Executive Officer, Director | Oct 3, 2025 | Sale(10b5-1 plan) | −2,400 | $2.55 | $6.12K | 371,692 |
| Scott Robert Henry Director | Oct 3, 2025 | Sale(10b5-1 plan) | −7,175 | $2.55 | $18.30K | 113,356 |
| Adam R. Levy Chief Executive Officer, Director | Oct 2, 2025 | Sale(10b5-1 plan) | −1,600 | $2.50 | $4.00K | 374,092 |
| Scott Robert Henry Director | Oct 2, 2025 | Sale(10b5-1 plan) | −825 | $2.50 | $2.06K | 120,531 |
| Scott Robert Henry Director | Sep 25, 2025 | Sale(10b5-1 plan) | −7,697 | $2.36 | $18.16K | 121,356 |
| Adam R. Levy Chief Executive Officer, Director | Aug 28, 2025 | Sale | −4,000 | $2.47 | $9.88K | 358,284 |
| Scott Robert Henry Director | Jun 13, 2025 | Sale(10b5-1 plan) | −3,000 | $2.57 | $7.71K | 129,053 |
| Adam R. Levy Chief Executive Officer, Director | Jun 11, 2025 | Sale | −2,000 | $2.39 | $4.78K | 362,284 |
| Adam R. Levy Chief Executive Officer, Director | Jun 9, 2025 | Sale | −2,000 | $2.33 | $4.66K | 364,284 |
| Adam R. Levy Chief Executive Officer, Director | Jun 5, 2025 | Sale | −1,000 | $2.32 | $2.32K | 366,284 |
| Adam R. Levy Chief Executive Officer, Director | Jun 4, 2025 | Sale | −1,000 | $2.29 | $2.29K | 367,284 |
| Adam R. Levy Chief Executive Officer, Director | May 30, 2025 | Sale | −1,000 | $2.22 | $2.22K | 368,284 |
| Adam R. Levy Chief Executive Officer, Director | May 16, 2025 | Sale | −1,000 | $2.58 | $2.58K | 369,284 |
| Scott Robert Henry Director | May 12, 2025 | Sale(10b5-1 plan) | −3,000 | $2.69 | $8.07K | 132,053 |
| Scott Robert Henry Director | Apr 10, 2025 | Sale(10b5-1 plan) | −3,000 | $2.61 | $7.83K | 135,053 |
| Adam R. Levy Chief Executive Officer, Director | Apr 1, 2025 | Sale(10b5-1 plan) | −4,000 | $3.01 | $12.04K | 370,284 |
| Scott Robert Henry Director | Mar 10, 2025 | Sale(10b5-1 plan) | −3,000 | $2.87 | $8.61K | 138,053 |
| Adam R. Levy Chief Executive Officer, Director | Mar 3, 2025 | Sale(10b5-1 plan) | −4,000 | $3.16 | $12.64K | 374,284 |
| steven mark glassman Director | Feb 12, 2025 | Award | +2,500 | – | – | 156,655 |
| Scott Robert Henry Director | Feb 12, 2025 | Award | +2,500 | – | – | 141,053 |
| Scott Robert Henry Director | Feb 10, 2025 | Sale(10b5-1 plan) | −3,000 | $3.27 | $9.81K | 138,553 |
| Adam R. Levy Chief Executive Officer, Director | Feb 3, 2025 | Sale(10b5-1 plan) | −4,000 | $3.64 | $14.56K | 378,284 |
| Scott Robert Henry Director | Jan 7, 2025 | Sale(10b5-1 plan) | −3,000 | $3.37 | $10.11K | 141,553 |
| Adam R. Levy Chief Executive Officer, Director | Jan 2, 2025 | Sale(10b5-1 plan) | −4,000 | $3.96 | $15.84K | 382,284 |
| Adam R. Levy Chief Executive Officer, Director | Jan 2, 2025 | Award | +26,116 | – | – | 386,284 |
| Scott Robert Henry Director | Dec 20, 2024 | Sale(10b5-1 plan) | −3,000 | $4.64 | $13.92K | 144,553 |
| Jerome B. Zeldis Director | Nov 20, 2024 | Buy | +3,636 | $2.75 | $10.00K | 106,664 |
| Scott Robert Henry Director | Nov 20, 2024 | Buy | +1,818 | $2.75 | $5.00K | 147,553 |
| Adam R. Levy Chief Executive Officer, Director | Nov 20, 2024 | Buy | +3,636 | $2.75 | $10.00K | 333,196 |
| John Nachum Stein Director | Nov 20, 2024 | Buy | +3,636 | $2.75 | $10.00K | 471,456 |
| Adam E. Drapczuk III Chief Financial Officer | Nov 20, 2024 | Buy | +17,500 | $2.75 | $48.13K | 74,894 |
| steven mark glassman Director | Nov 20, 2024 | Buy | +9,090 | $2.75 | $25.00K | 154,155 |
| John Nachum Stein Director | Nov 7, 2024 | Gift | −4,000 | – | – | 467,820 |
| John Nachum Stein Director | Aug 23, 2024 | Buy | +10,000 | $2.50 | $25.00K | 471,820 |
| steven mark glassman Director | Aug 23, 2024 | Buy | +10,000 | $2.50 | $25.00K | 145,025 |
| Scott Robert Henry Director | Aug 23, 2024 | Buy | +10,000 | $2.50 | $25.00K | 145,735 |
| Jerome B. Zeldis Director | Aug 23, 2024 | Buy | +10,000 | $2.50 | $25.00K | 103,028 |
| Adam E. Drapczuk III Chief Financial Officer | Aug 23, 2024 | Buy | +10,000 | $2.50 | $25.00K | 57,394 |
| steven mark glassman Director | Mar 1, 2024 | Buy | +11,848 | $2.11 | $25.00K | 135,025 |
| Adam E. Drapczuk III Chief Financial Officer | Mar 1, 2024 | Buy | +47,394 | $2.11 | $100.00K | 47,394 |
| Scott Robert Henry Director | Mar 1, 2024 | Buy | +23,697 | $2.11 | $50.00K | 135,735 |
| steven mark glassman Director | Dec 22, 2023 | Buy | +3,885 | $2.20 | $8.55K | 123,177 |
| John Nachum Stein Director | Sep 26, 2023 | Buy | +2,500 | $1.96 | $4.90K | 500,019 |
| Scott Robert Henry Director | Sep 14, 2023 | Buy | +500 | $2.27 | $1.14K | 112,038 |
| Scott Robert Henry Director | Sep 13, 2023 | Buy | +6,000 | $2.25 | $13.50K | 111,538 |
| Scott Robert Henry Director | Sep 12, 2023 | Buy | +4,000 | $2.28 | $9.12K | 105,538 |
| Scott Robert Henry Director | Aug 22, 2023 | Buy | +980 | $1.92 | $1.88K | 101,538 |
| Scott Robert Henry Director | Aug 21, 2023 | Buy | +2,000 | $1.95 | $3.90K | 100,558 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 15, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
-24.8%
From 0M shares
Short volume, 20 days
82.2%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Nexgel's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,052 shares on Aug 17, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Adam R. Levy Affilaite | Sep 30, 2026 | 249,456 | $44.70K | Sep 29, 2026 | Various: Open Market Purchases and Stock Grants as part of equity compensation |
| Adam R. Levy Officer | May 27, 2026 | 50,000 | $27.07K | May 27, 2026 | Compensation |
| Adam R. Levy Officer | Dec 22, 2025 | 10,000 | $16.40K | Dec 22, 2025 | Equity Compensation |
| Adam R. Levy Officer, Director | Oct 2, 2025 | 16,000 | $40.00K | Oct 2, 2025 | COMPENSATION |
| Scott Robert Henry Director | Sep 25, 2025 | 35,515 | $108.45K | Sep 25, 2025 | COMPENSATION / DEAL ACQUIRED BETWEN: 2/15/24 TO 11/5/24 |
| Adam R. Levy Officer | Aug 28, 2025 | 4,000 | $9.80K | Aug 28, 2025 | Various: Founder Shares, PIPE, ESOP, Open Market Purchases |
| Adam R. Levy Officer | May 16, 2025 | 8,000 | $18.96K | May 16, 2025 | RSU Vesting |
| Scott Robert Henry Director | Apr 10, 2025 | 9,000 | $23.40K | Apr 10, 2025 | OPEN MARKET PURCHASES |
| Adam R. Levy Officer, Director | Jan 2, 2025 | 16,000 | $64.48K | Jan 2, 2025 | COMPENSATION |
| Scott Robert Henry Director | Dec 20, 2024 | 12,000 | $55.62K | Dec 20, 2024 | OPEN MARKET PURCHASES |